PPG
40
5
KMI
61
4
CLX
56
6
LRCX
43
-2
MKC
57
7
BDX
33
-3
MO
66
3
PLD
43
3
EL
23
6
CTSH
42
-2
L
49
-5
FIS
78
16
CHRW
64
8
DE
55
12
PNC
52
2
DHI
39
7
AVGO
42
16
BAC
41
2
ILMN
35
12
AMG
44
-5
PPG
40
5
KMI
61
4
CLX
56
6
LRCX
43
-2
MKC
57
7
BDX
33
-3
MO
66
3
PLD
43
3
EL
23
6
CTSH
42
-2
L
49
-5
FIS
78
16
CHRW
64
8
DE
55
12
PNC
52
2
DHI
39
7
AVGO
42
16
BAC
41
2
ILMN
35
12
AMG
44
-5
Financhill
Back

NeuroPace Stock Predictions

Mode Mobile Could be Next in Line"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34

NPCE
NeuroPace

Last Price:
$10.80
Seasonality Move:
-33.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Mode Mobile Could be Next in Line

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

NeuroPace Stock Forecast

  • Over the next 52 weeks, NeuroPace has on average historically risen by 46.7% based on the past 3 years of stock performance.
  • NeuroPace has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is NeuroPace Stock Undervalued?
    The current NeuroPace [NPCE] share price is $10.79. The Score for NPCE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • NPCE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will NeuroPace Stock Go Up Next Year?

  • Over the next 52 weeks, NeuroPace has on average historically risen by 46.7% based on the past 3 years of stock performance.

NeuroPace Stock Rating

Sell
34
NeuroPace (NPCE) is a Sell

Is NeuroPace overpriced?

  • NeuroPace has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

NeuroPace Stock Price History

Is NPCE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NPCE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
neuropace.com

52-Week Data

52-Week High:
15.11
52-Week Low:
5.45

Prediction Charts

Market Cap:
351.3M
Price in USD:
10.79
Volume:
173.1K
Beta:
2.04

Technical Analysis

SMA50:
12.12
SMA100:
11.92
SMA200:
9.55
52-Wk Change:
-21.53%

Stock Predictions

  • Is NeuroPace stock public?
    Yes, NeuroPace is a publicly traded company.
  • What is the NeuroPace stock quote today?
    The NeuroPace stock price is 10.79 USD today.
  • How to buy NeuroPace stock online?
    You can buy NeuroPace shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-31 11.57 12.29 12.45 11.26
Apr-1 12.16 13.11 13.18 11.85
Apr-2 12.86 13.54 13.60 12.54
Apr-3 13.01 13.01 13.04 12.00
Apr-4 12.40 12.23 12.68 11.83
Apr-7 11.44 12.30 12.67 11.03
Apr-8 12.55 11.10 12.55 10.84
Apr-9 10.88 11.67 12.01 10.18
Apr-10 11.19 10.64 11.56 10.43
Apr-11 10.54 10.42 10.75 9.89
Apr-14 10.74 10.67 10.95 10.44
Apr-15 10.72 10.34 11.51 10.26
Apr-16 10.15 10.43 10.57 10.15
Apr-17 10.42 10.79 10.95 10.25

NeuroPace Earnings

NeuroPace Earnings Report: Per Share NeuroPace Earnings Q1 Q2 Q3 and Q4 last year and next year.

NeuroPace Forecast Revenue Growth

NeuroPace Stock Analysis: Historical quarterly revenues per share for NeuroPace and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.06 per share, an increase this year of $0.15 per share, and an increase next year of $0.30 per share.

* NeuroPace stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.